Norika Akashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Norika Akashi has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Masashi Akiyama
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
11 shared publications - Yoshinao Muro
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
11 shared publications - Haruka Koizumi
Department of Dermatology Toyota Memorial Hospital Toyota Aichi Japan
10 shared publications - Mariko Ogawa-Momohara
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Aichi Japan
10 shared publications - Yuta Yamashita
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
9 shared publications Satoshi Kamiya
Department of Dermatology Nagoya University Graduate School of Medicine Nagoya Japan
7 shared publications
Latest Publications
- 10 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7)
Paraspinal Muscle Atrophy on Chest CT as a Prognostic Marker for Anti‐Aminoacyl‐ tRNA Synthetase Antibody‐Positive Myositis
- 10 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (7)
Paraspinal Muscle Atrophy on Chest CT as a Prognostic Marker for Anti‐Aminoacyl‐ tRNA Synthetase Antibody‐Positive Myositis
- 1 October 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (12)
Anti‐Ki/ SL Antibody‐Positive Deep Morphea Patient Also Positive for Anti‐ PL ‐12 and Anti‐Ro60 Antibodies
- 1 October 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (12)
Anti‐Ki/ SL Antibody‐Positive Deep Morphea Patient Also Positive for Anti‐ PL ‐12 and Anti‐Ro60 Antibodies
- 5 August 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (10)
Immune Checkpoint Inhibitor‐Induced IgA Vasculitis With Abundant IgA Anti‐Endothelial Cell Antibodies
- 5 August 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (10)
Immune Checkpoint Inhibitor‐Induced IgA Vasculitis With Abundant IgA Anti‐Endothelial Cell Antibodies
- 22 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (10)
A Case of Rituximab Successfully Controlling SSc Vascular and Other Symptoms in a Pregnant Patient, Leading to a Safe Pregnancy and Delivery
- 22 July 2025
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (10)
A Case of Rituximab Successfully Controlling SSc Vascular and Other Symptoms in a Pregnant Patient, Leading to a Safe Pregnancy and Delivery
- 25 April 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (8) , 1679-1682
Expanding the relevance of anti-Ki/SL beyond systemic lupus erythematosus to systemic sclerosis and dermatomyositis in in-house enzyme-linked immunosorbent assay analyses
Anti-Ki/SL antibodies are most commonly found in patients with systemic lupus erythematosus, they show broader relevance to systemic sclerosis and dermatomyositis. We developed an in-house enzyme-linked immunosorbent assay for anti-Ki/SL antibodies that are not included in the line blot assay.
- 25 April 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (8) , 1679-1682
Expanding the relevance of anti-Ki/SL beyond systemic lupus erythematosus to systemic sclerosis and dermatomyositis in in-house enzyme-linked immunosorbent assay analyses
Anti-Ki/SL antibodies are most commonly found in patients with systemic lupus erythematosus, they show broader relevance to systemic sclerosis and dermatomyositis. We developed an in-house enzyme-linked immunosorbent assay for anti-Ki/SL antibodies that are not included in the line blot assay.